Sugi Predict

Sugi Predict / Compounds / SCHEMBL4331306

SCHEMBL4331306

SCHEMBL4331306

c1ccc(-c2cccc3cc4c(-c5ccccc5)cccc4cc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.53
▸ ALDH1A1 P00352 8/20 0.52
▸ HPGD P15428 5/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ MPI P34949 1/20 0.52
▸ HSD17B1 P14061 1/20 0.47
▸ HSD17B2 P37059 1/20 0.47
▸ HSD17B10 Q99714 6/20 0.45
▸ MAPK1 P28482 4/20 0.45
▸ HIF1A Q16665 3/20 0.45
▸ TSHR P16473 3/20 0.45
▸ CASP1 P29466 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ BACE1 P56817 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ METAP2 P50579 1/20 0.44
▸ CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30645491 1.00 TNF (0.53) TNFALDH1A1HPGDKDM4EMEN1
Biphenyl SCHEMBL20533557 0.98 TNF (0.52) TNFALDH1A1HPGDKDM4EMEN1
Biphenyl SCHEMBL28236205 0.98 TNF (0.52) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL60347 0.95 TNF (0.50) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL30332794 0.95 TNF (0.50) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL23327305 0.93 TNF (0.48) TNFALDH1A1HPGDKDM4EMEN1
Hydrogen Sulfide SCHEMBL9349313 0.93 TNF (0.48) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL1309613 0.93 TNF (0.48) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL3260909 0.93 TNF (0.48) TNFALDH1A1HPGDKDM4EMEN1
SCHEMBL28848951 0.93 TNF (0.48) TNFALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117050254-A Anthracene type covalent organic framework material and preparation method and application thereof 南京邮电大学 2023-11-14 — — CN disclosed
US-8766023-B2 Synthesis process LG DISPLAY CO., LTD. (KR) 2014-07-01 — — US disclosed
EP-1669428-B1 Organic electroluminescent devices LG DISPLAY CO LTD (KR) 2013-07-24 — — EP disclosed
US-7638206-B2 Bifunctional compounds and OLED using the same LG DISPLAY CO., LTD. (KR) 2009-12-29 — — US disclosed
US-7622619-B2 Making 9,10-diarylanthracenes such as 2-tert-butyl-9,10-bis-(beta-napthyl)-anthracene (TBADN); material for Organic light emitting devices (OLEDs) LG DISPLAY CO., LTD. (KR) 2009-11-24 — — US disclosed
CN-100519690-C Organic electroluminescent devices LG DISPLAY CO LTD (KR) 2009-07-29 — — CN disclosed
US-7402346-B2 Organic electroluminescent devices LG. PHILIPS LCD CO., LTD. (KR) 2008-07-22 — — US disclosed
US-7291404-B2 Organic light emitting devices LG.PHILIPS LCD CO., LTD. (KR) 2007-11-06 — — US disclosed
US-20070141390-A1 Bifunctional compounds and OLED using the same LG.PHILIPS LCD CO., LTD. (KR) 2007-06-21 — — US disclosed
US-20070020480-A1 Synthesis process XEROX CORPORATION 2007-01-25 — — US disclosed
US-20060121311-A1 Organic electroluminescent devices XEROX CORPORATION. 2006-06-08 — — US disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 — — US disclosed
US-20040209117-A1 Organic light emitting devices XEROX CORPORATION 2004-10-21 — — US disclosed
US-6562485-B2 Electroluminescent (EL) devices XEROX CORPORATION 2003-05-13 — — US disclosed
US-20030044646-A1 Electroluminescent (EL) devices XEROX CORPORATION 2003-03-06 — — US disclosed
US-6479172-B2 PERFORMANCE, THERMOSTABILITY XEROX CORPORATION 2002-11-12 — — US disclosed
US-20020132134-A1 Electroluminescent (EL) devices XEROX CORPORATION 2002-09-19 — — US disclosed
US-6229012-B1 ORGANIC ELECTROLUMINESCENT DEVICES XEROX CORPORATION 2001-05-08 — — US disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 — — US disclosed
US-6057048-A Electroluminescent (EL) devices XEROX CORPORATION (US) 2000-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070020480-A1 Synthesis process ALAD, FDPS, ALKBH1 TNF 3592/4885ALDH1A1 1158/4885HPGD 627/4885
US-20040209117-A1 Organic light emitting devices OXA1L, OCIAD1, SLCO4C1 TNF 3513/4885ALDH1A1 240/4885HPGD 1650/4885
US-20060121311-A1 Organic electroluminescent devices KCNH3, GLUL, ARGLU1 TNF 4789/4885ALDH1A1 588/4885HPGD 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.